The first and only filler to correct age-related volume loss in the midface for up to 2 years.
AGING IN THE MIDFACE
The approach to facial aesthetics has evolved from filling lines to addressing the 3-dimensional effects of aging—particularly restoring age-related volume loss in the midface.
The ogee curve
The ogee curve describes the curve from the cheekbone to the midface hollow. The goal of midface enhancement is to restore the ogee curve.
VOLUMA® is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the midface in adults over the age of 21.
Unique VYCROSS® technology customized for lift and duration
Efficiently and tightly cross-linked gel
Proprietary mixture of low- and high-molecular–weight HA produces an efficiently and tightly cross-linked gel, which contributes to its lift capacity and duration
Formulated for deep injection
Indicated for injection into the subcutaneous and/or supraperiosteal planes.
UNIQUE FORMULATIONVOLUMA® contains 0.3% lidocaine and uses proprietary VYCROSS® technology to create an efficiently cross-linked gel with 20 mg/mL of HA.
LOW HYDROPHILICITYIn vitro study shows VOLUMA® has a low capacity for water absorption. Clinical significance of these in vitro data is unknown.
SMOOTH EXTRUSIONVYCROSS® technology produces a gel that allows for smooth extrusion
For age-related volume loss in the midface LIFT THAT LASTS
- 67.1% of patients maintained a clinically significant response through 2 years with optimal treatment
For age-related volume loss in the midface LASTING LIFT TO SATISFY PATIENTS
MORE YOUTHFUL LOOK
For age-related volume loss in the midface MORE YOUTHFUL LOOK
Disclaimer: Individual results may vary from patient to patient and there is no guarantee of specific results.